Non-alcoholic fatty pancreas disease

Postgraduate Medical Journal

Volumn 93, Issue 1098, 2017, Pages 226-230

  Alempijevic, Tamara ^a,b   Dragasevic, Sanja ^a   Zec, Simon ^b   Popovic, Dragan ^a,b   Milosavljevic, Tomica ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE PANCREATITIS; BODY FAT; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FATTY LIVER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON ALCOHOLIC FATTY PANCREASNON-ALCOHOLIC FATTY PANCREAS DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PANCREAS CARCINOMA; PANCREAS DISEASE; REVIEW; RISK FACTOR; COMPLICATION; HYPERLIPIDEMIA; METABOLISM; NONALCOHOLIC FATTY LIVER; PANCREAS; PANCREATIC DISEASES; PATHOLOGY; PATHOPHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPIDEMIAS; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PANCREAS; PANCREATIC DISEASES; RISK FACTORS;

EID: 85017191813     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2016-134546     Document Type: Review

References (41)

1. Mishra AK, Dubey V, Ghosh AR. Obesity: an overview of possible role(s) of gut hormones, lipid sensing and gut microbiota. Metab Clin Exp 2016;65:48-65.
2. WHO. Obesity and overweight: fact sheet. World Health Organisation. http://www. who.int/mediacentre/factsheets/fs311/en/ (accessed 20 Sept 2016).
3. Di Ciaula A, Portincasa P. Fat, epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Med 2014;25:865-73.
4. Della Corte C, Mosca A, Majo F, et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf) 2015;83:656-62.
5. Ou HY, Wang CY, Yang YC, et al. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS ONE 2013;8:e62561.
6. Al-Haddad M, Khashab M, Zyromski N, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 2009;38:672-5.
7. Choi CW, Kim GH, Kang DH, et al. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World J Gastroenterol 2010;16:4329-34.
8. Lingvay I, Esser V, Legendre JL, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009;94:4070-6.
9. Schwenzer NF, Machann J, Martirosian P, et al Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008;43:330-7.
10. Jeong HT, Lee MS, Kim MJ. Quantitative analysis of pancreatic echogenicity on transabdominal sonography: correlations with metabolic syndrome. J Clin Ultrasound 2015;43:98-108.
11. Ambesh P, Lal H. Pancreatic lipomatosis: complete replacement of pancreas by fat. J Clin Diagn Res 2015;9:OL01.
12. Soyer P, Spelle L, Pelage JP, et al. Cystic fibrosis in adolescents and adults: fatty replacement of the pancreas—CT evaluation and functional correlation. Radiology 1999;210:611-15.
13. Schaefer JH. The normal weight of the pancreas in the adult human being: a biometric study. Anat Rec (Hoboken) 1926;32:119-32.
14. Ogilvie RF. The islands of Langerhans in 19 cases of obesity. J Pathol Bacteriol 1933;37:473-81.
15. Shimabukuro M, Zhou YT, Levi M, et al. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998;95:2498-502.
16. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007;9:312-18.
17. Zhang X, Cui Y, Fang L, et al. Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas 2008;37:e31-8.
18. Sepe PS, Ohri A, Sanaka S, et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 2011;73:987-93.
19. Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009;15:1869-75.
20. Hannukainen JC, Borra R, Linderborg K, et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol 2011;54:545-52.
21. Rossi AP, Fantin F, Zamboni GA, et al. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity (Silver Spring) 2011;19:1747-54.
22. Lê KA, Ventura EE, Fisher JQ, et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care 2011;34:485-90.
23. Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. Cardiovasc Diabetol 2013;12:77.
24. Uygun A, Kadayifci A, Demirci H, et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med 2015;26:37-41.
25. van Geenen EJ, Smits MM, Schreuder TC, et al. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 2010;39:1185-90.
26. Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010;26:200-5.
27. Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 2011;8:169-77.
28. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007;30:2916-21.
29. van der Zijl NJ, Goossens GH, Moors CC, et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 2011;96:459-67.
30. Mirrakhimov AE. Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea? Cardiovasc Diabetol 2014;13:29.
31. Acharya C, Navina S, Singh VP. Role of pancreatic fat in the outcomes of pancreatitis. Pancreatology 2014;14:403-8.
32. Papachristou GI, Papachristou DJ, Avula H, et al. Obesity increases the severity of acute pancreatitis: performance of apache-o score and correlation with the inflammatory response. Pancreatology 2006;6:279-85.
33. Shin KY, Lee WS, Chung DW, et al. Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver 2011;5:335-9.
34. Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med 2011;3:107ra110.
35. Acharya C, Cline RA, Jaligama D, et al. Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology 2013;145:466-75.
36. Fuks D, Piessen G, Huet E, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg 2009;197:702-9.
37. Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 2010;148:15-23.
38. Rosso E, Casnedi S, Pessaux P, et al. The role of “fatty pancreas” and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg 2009;13:1845-51.
39. Tranchart H, Gaujoux S, Rebours V, et al. Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg 2012;256:139-45.
40. Søreide K, Labori KJ. Risk factors and preventive strategies for post-operative pancreatic fistula after pancreatic surgery: a comprehensive review. Scand J Gastroenterol 2016;51:1147-54.
41. Tomita Y, Azuma K, Nonaka Y, et al. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Pancreas 2014;43:1032-41.